prostate header graphic
Prostate Problem Guide

Prostate Medicine Used For The Treatment Of An Enlarged Prostate

Although the majority of men in the 60s and 70s will suffer from an enlarged prostate a significant proportion will have very few symptoms or will experience a range of relatively mild symptoms and will be happy to live with these without treatment as one of the inevitable consequences of growing old. For others however the symptoms produced by an enlarged prostate will be troublesome enough for them to seek prostate medicine from their doctor.

The first line of attack is normally to prescribe one of two groups of drugs commonly used in cases of an enlarged prostate (otherwise often referred to as benign prostatic hyperplasia, benign prostatic hypertrophy or BPH).

The first group of drugs is known as "alpha-blockers". Originally used in the treatment of hypertension (high blood pressure), these drugs act by relaxing the muscles of both the prostate gland and the neck of the bladder and remove pressure on the urethra to ease the flow of urine.

Alpha-blockers are normally taken orally once or twice a day and act immediately. Some of the side-effects can include dizziness, light-headedness, headaches, tiredness, difficulties in breathing and stomach and intestinal problems.

One important thing to remember about alpha-blockers is that they do not actually reduce the size of the prostate and that their effect will only be felt for as long as you continue taking the tablets.

The second group of drugs is known as "5-alpha reductase inhibitors". These drugs act to reduce the level of male hormone within the prostate gland which, in turn, cause the prostate gland itself to shrink slightly. This can however be a slow process and most patients will need to take 5-alpha reductase inhibitors for 6 to 12 months before the effects are felt.

5-alpha reductase inhibitors are normally taken orally once a day and side effects can include erectile dysfunction, a decrease in sexual desire and a reduction in the amount of semen produced during ejaculation.

As both alpha-blockers and 5-alpha reductase inhibitors act quite differently to reduce prostate symptoms it is not uncommon to enhance the effects of treatment by prescribing both drugs together.

Further information on prostate medicine:

Drug Scare Shenanigans - FOXNews


Canada.com

Drug Scare Shenanigans
FOXNews - Sep 4, 2008
Moreover, for the three specific cancers with reported risks closest to attaining statistical significance in the SEAS trial -- skin, stomach and prostate ...
Vytorin cancer cause or cholesterol cure PRESS TV
Vytorin rides out choppy SEAS TheHeart.Org
Vytorin Rides Out Choppy SEAS Medscape (subscription)
all 557 news articles

Patients 'facing scan delays because of radiation shortage' - Telegraph.co.uk


Patients 'facing scan delays because of radiation shortage'
Telegraph.co.uk, United Kingdom - Sep 5, 2008
Professor Alan Perkins, honorary secretary of the British Nuclear Medicine Society, said that patients who had less urgent need for the scans, ...

LA Clippers team physician dead at 74 - International Herald Tribune


LA Clippers team physician dead at 74
International Herald Tribune, France - Sep 5, 2008
Daly died at his home Friday following a lengthy battle with prostate cancer, said Dr. Robert S. Bray Jr., the executive director and founder of DISC Spine ...

Cancer links to obesity revealed in new study - Telegraph.co.uk


Cancer links to obesity revealed in new study
Telegraph.co.uk, United Kingdom - Sep 6, 2008
Links between prostate cancer and obesity were less clear. However, men who put on more than 10 per cent of their body weight and had a BMI greater than ...
Obese more likely to develop cancer Times of India
all 26 news articles